MARKET COMPOSITE
CMPS - Compass Pathways Plc3:54:21 PM 4/23/2024
Price
$8.49
+ 0.13 (1.56%)
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news

    LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the 23rd Annual Needham Virtual Healthcare Conference at 8:00am ET on April 9, 2024. A live audio webcast of the presentation will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible

    In this article, we will be taking a look at the 20 most depressed countries in Asia. If you do not want to learn about the Asian depression market, head straight to the 5 Most Depressed Countries in Asia. Overview of the Global and Asian Depression Market The global depression market is a significant sector […]

    David Norton Assumes Role of Interim Board Chair while the Company Runs a Global Search for a New ChairLONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that Board Chair and co-founder George Goldsmith and fellow co-founder Ekaterina Malievskaia have resigned their seats on the company’s board of directors, effective March 29, 2

    In this article, we will be taking a look at the 10 alternatives to antidepressant medications. If you do not want to learn about the global antidepressant market, head straight to the 5 Alternatives to Antidepressant Medications. In recent years, the conversation surrounding mental health treatment has expanded beyond traditional pharmaceutical interventions, prompting exploration into […]

    In this article, we discuss the 15 Highest Paying Jobs with a Psychology Degree. If you want to read about some more Highest Paying Jobs with a Psychology Degree, go directly to 5 Highest Paying Jobs with a Psychology Degree. In the dynamic landscape of mental health, the global market has been witnessing an extraordinary […]

    In this article, we will be taking a look at the 20 countries with most antidepressant users in the world. If you do not want to learn about the global antidepressant market, head straight to the 5 Countries with Most Antidepressant Users in the World. In today’s global landscape, mental health awareness and treatment have […]

    COMPASS Pathways plc (NASDAQ:CMPS) Q4 2023 Earnings Call Transcript February 29, 2024 COMPASS Pathways plc misses on earnings expectations. Reported EPS is $-0.53 EPS, expectations were $-0.37. COMPASS Pathways plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]

    CMPS earnings call for the period ending December 31, 2023.

    Compass Pathways Announces Q4 2023 Financial Results and Business Highlights

    LONDON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Highlights: COMP360 phase 3 pivotal program ongoing; COMP005 trial top-line data now expected in fourth quarter 2024, COMP006 remains on track for top-line data in mid-2025Teri Loxam to assume Chief Financial Officer role on March 1, 2024Cash position of $220.2 million at December 31, 2023, additional $31.4 million net cash raised to date in first quarter 2024Conference call February 29 at 8:00 am ET (1:00 pm UK) Compass Pathways plc (Nasdaq: CMPS) (“Com